SOLIFENACINE VIATRIS 5 mg, film-coated tablet 30 tablets, CIP 3400930040775
Active ingredients: Solifenacin, Solifenacin succinate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400930040775orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SOLIFENACINE VIATRIS 5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Jun 2019
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67637196CIP73004077CIP133400930040775Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUCCINATE DE SOLIFÉNACINEcomprimé | 5 mg · un comprimé | SA |
| SOLIFÉNACINEcomprimé | 3,8 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.